2022
DOI: 10.1136/bmjophth-2022-001014
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous lipo-prostaglandin E1 administration for patients with acute central retinal artery occlusion

Abstract: ObjectiveThis study aimed to investigate the anatomical and functional changes in patients with central retinal artery occlusion (CRAO) (n=21) treated with 10 µg/day intravenous liposomal prostaglandin E1 (lipo-PGE1).Methods and analysisWe used best-corrected visual acuity (BCVA), central retinal thickness with spectral domain optical coherence photography, optical intensity ratio (OIR) with imageJ software and retinal vessel diameter with fundus photography as indicators. Data were analysed using Tukey’s mult… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 27 publications
0
0
0
Order By: Relevance